Bruker Corporation (NASDAQ:BRKR) Plans $0.05 Quarterly Dividend

Bruker Corporation (NASDAQ:BRKR) announced a quarterly dividend on Thursday, May 14th. Shareholders of record on Monday, June 22nd will be paid a dividend of 0.05 per share by the medical research company on Tuesday, July 7th. This represents a c) annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, June 22nd.

Bruker has raised its dividend payment by an average of 0.0%per year over the last three years. Bruker has a payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Research analysts expect Bruker to earn $2.44 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 8.2%.

Bruker Stock Performance

BRKR stock opened at $57.23 on Friday. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67. The business’s fifty day simple moving average is $46.54 and its two-hundred day simple moving average is $44.14. Bruker has a twelve month low of $28.53 and a twelve month high of $64.54. The firm has a market cap of $8.71 billion, a price-to-earnings ratio of -238.46, a PEG ratio of 1.83 and a beta of 1.31.

Bruker (NASDAQ:BRKR) last released its earnings results on Wednesday, May 6th. The medical research company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.08. The business had revenue of $823.40 million during the quarter, compared to the consensus estimate of $795.62 million. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the company earned $0.47 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Analysts predict that Bruker will post 2.12 earnings per share for the current year.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.